By Medtronic, Inc.


Medtronic ScreenLink is a device designed to be used by well being care professionals (HCPs) in order to facilitate the quality of care improvement, helping to make certain that access to gadget therapy offered to heart failure, post-MI, SCA/VF/VT, bradycardia, atrial fibrillation and unexplained syncope patients is aligned with the most recent European and UK scientific pointers.

Healthcare suppliers who use the ScreenLink tool are armed with the newest evidence-based ICD/CRT/PM/AFS and Diagnosis and Management of Syncope European and UK scientific tips gaining instant access to gadget therapy determination assist.

NOTE: Patients affected by Brugada or Long-QT syndromes usually are not evaluated by this system. The ScreenLink app derives from a bigger so referred to as net utility with an identical objective including the flexibility to hyperlink healthcare suppliers alongside the medical patient pathway, enabling improved and extra co-ordinated care. Patients with particular condition such as (but not restricted to) acute myocardial infarction, hypertrophic cardiomyopathy or lengthy QT syndrome are not evaluated by this system.

To be taught more

DISCLAIMER: This utility is the copyrighted property of Medtronic. It has been approved by Medtronic just for use with the suitable Medtronic merchandise. Please contact Medtronic should you wish to use this application for another objective.